Therapeutic dendritic-cell vaccine for simian AIDS (original) (raw)

• Kostense, S. et al. Persistent numbers of tetramer(+) CD8(+) T cells, but loss of interferon-γ(+) HIV-specific T cells during progression to AIDS. Blood 99, 2505–2511 (2002).
  Article CAS PubMed Google Scholar
• Barouch, D.H. et al. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 415, 335–339 (2002).
  Article CAS PubMed Google Scholar
• Lieberman, J., Shankar, P., Manjunath, N. & Andersson, J. Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood 98, 1667–1677 (2001).
  Article CAS PubMed Google Scholar
• Champagne, P. et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410, 106–111 (2001).
  Article CAS PubMed Google Scholar
• Cohen, O.J., Kinter, A. & Fauci, A.S. Host factors in the pathogenesis of HIV disease. Immunol. Rev. 159, 31–48 (1997).
  Article CAS PubMed Google Scholar
• Fenyo, E.M. & Putkonen, P. Broad cross-neutralizing activity in serum is associated with slow progression and low risk of transmission in primate lentivirus infections. Immunol. Lett. 51, 95–99 (1996).
  Article CAS PubMed Google Scholar
• Knight, S.C. & Stagg, A.J. Antigen-presenting cell types. Curr. Opin. Immunol. 5, 374–382 (1993).
  Article CAS PubMed Google Scholar
• Rossio, J.L. et al. Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. J. Virol. 72, 7992–8001 (1998).
  CAS PubMed PubMed Central Google Scholar
• Buseyne, F. et al. MHC-I-restricted presentation of HIV-1 virion antigens without viral replication. Nature Med. 7, 344–349 (2001).
  Article CAS PubMed Google Scholar
• Mehlhop, E. et al. Enhanced in vitro stimulation of rhesus macaque dendritic cells for activation of SIV-specific T cell responses. J. Immunol. Methods 260, 219–234 (2002).
  Article CAS PubMed Google Scholar
• Sapp, M. et al. Dendritic cells generated from blood monocytes of HIV-1 patients are not infected and act as competent antigen presenting cells eliciting potent T-cell responses. Immunol. Lett. 66, 121–128 (1999).
  Article CAS PubMed Google Scholar
• Chougnet, C. et al. Normal immune function of monocyte-derived dendritic cells from HIV-infected individuals: implications for immunotherapy. J. Immunol. 163, 1666–1673 (1999).
  CAS PubMed Google Scholar
• Lu, W., Achour, A., Arlie, M., Cao, L. & Andrieu, J.M. Enhanced dendritic-cells-driven proliferation and anti-HIV activity of CD8+ T cells by a new phenothiazine derivative aminoperazine. J. Immunol. 167, 2929–2935 (2001).
  Article CAS PubMed Google Scholar
• Lu, W. & Andrieu, J.M. In vitro HIV eradication by autologous CD8+ T cells expanded with inactivated-virus-pulsed dendritic cells. J. Virol. 75, 8949–8956 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Hirsch, V.M. & Lifson, J.D. Simian immunodeficiency virus infection of monkeys as a model system for the study of AIDS pathogenesis, treatment, and prevention. Adv. Pharmacol. 49, 437–477 (2000).
  Article CAS PubMed Google Scholar
• Lu, W., Cao, L., Ty, L., Arlie, M. & Andrieu, J.M. Equivalent amplification of intrinsically variable nucleic acid sequences by multiple-primer-induced overlapping amplification assay: applications for universal detection and quantitation. Nature Med. 5, 1081–1085 (1999).
  Article CAS PubMed Google Scholar
• Nair, S.K. et al. Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. Nature Biotechnol. 16, 364–369 (1998).
  Article CAS Google Scholar
• Salerno-Goncalves, R., Lu, W. & Andrieu, J.M. Quantitative analysis of the antiviral activity of CD8(+) T cells from human immunodeficiency virus-positive asymptomatic patients with different rates of CD4(+) T-cell decrease. J. Virol. 74, 6648–6651 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Lu, W. & Andrieu, J.M. Prospective views of HIV pathology. Clues for therapeutic strategies. Adv. Exp. Med. Biol. 374, 235–242 (1995).
  Article CAS PubMed Google Scholar
• Andrieu, J.M. & Lu, W. Viro-immunopathogenesis of HIV disease: implications for therapy. Immunol. Today 16, 5–7 (1995).
  Article CAS PubMed Google Scholar
• Hermans, I.F., Ritchie, D.S., Yang, J., Roberts, J.M. & Ronchese, F. CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity. J. Immunol. 164, 3095–3101 (2000).
  Article CAS PubMed Google Scholar
• Norbury, C.C., Malide, D., Gibbs, J.S., Bennink, J.R. & Yewdell, J.W. Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo. Nature Immunol. 3, 265–271 (2002).
  Article CAS Google Scholar
• McIlroy, D. et al. Low CD83, but normal MHC class II and costimulatory molecule expression, on spleen dendritic cells from HIV+ patients. AIDS Res. Hum. Retroviruses 14, 505–513 (1998).
  Article CAS PubMed Google Scholar
• Zimmer, M.I. et al. Disrupted homeostasis of Langerhans cells and interdigitating dendritic cells in monkeys with AIDS. Blood 99, 2859–2868 (2002).
  Article CAS PubMed Google Scholar
• Ludewig, B. et al. Protective antiviral cytotoxic T cell memory is most efficiently maintained by restimulation via dendritic cells. J. Immunol. 163, 1839–1844 (1999).
  CAS PubMed Google Scholar
• Jin, X. et al. An antigenic threshold for maintaining human immunodeficiency virus type 1-specific cytotoxic T lymphocytes. Mol. Med. 6, 803–809 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Kalams, S.A. et al. Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy. J. Virol. 73, 6721–6728 (1999).
  CAS PubMed PubMed Central Google Scholar
• Gray, C.M. et al. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART). J. Immunol. 162, 1780–1788 (1999).
  CAS PubMed Google Scholar
• Pacanowski, J. et al. Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection. Blood 98, 3016–3021 (2001).
  Article CAS PubMed Google Scholar
• Feldman, S. et al. Decreased interferon-α production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors. Clin. Immunol. 101, 201–210 (2001).
  Article CAS PubMed Google Scholar
• Donaghy, H. et al. Loss of blood CD11c(+) myeloid and CD11c(−) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood 98, 2574–2576 (2001).
  Article CAS PubMed Google Scholar
• Grassi, F. et al. Depletion in blood CD11c-positive dendritic cells from HIV-infected patients. Aids 13, 759–766 (1999).
  Article CAS PubMed Google Scholar
• Grabar, S. et al. Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy. Ann. Intern. Med. 133, 401–410 (2000).
  Article CAS PubMed Google Scholar
• Lederman, M.M. & Valdez, H. Immune restoration with antiretroviral therapies: implications for clinical management. JAMA 284, 223–228 (2000).
  Article CAS PubMed Google Scholar
• Hatano, H. et al. Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression. Aids 14, 1357–1363 (2000).
  Article CAS PubMed Google Scholar
• Davey, R.T. Jr. et al. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc. Natl. Acad. Sci. USA 96, 15109–15114 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Lu, W. & Andrieu, J.M. HIV protease inhibitors restore impaired T-cell proliferative response in vivo and in vitro: a viral-suppression-independent mechanism. Blood 96, 250–258 (2000).
  CAS PubMed Google Scholar